openPR Logo
Press release

Solitary Fibrous Tumor (SFT) Treatment Market: Growth and Sales Forecast 2017 – 2025

02-27-2018 03:57 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Solitary Fibrous Tumor (SFT) Treatment Market: Growth and Sales

Solitary fibrous tumor (SFT) is a rare type of tumor. It generally comprises a spectrum of benign mesenchymal tumors that have thick collagen with hemangiopericytoma. Some of them can grow as malignant tumors. SFTs were first described in 1931 and they were recognized by several different names viz. pleural fibroma, benign mesothelioma, sub-serosal fibroma, localized fibrous tumor, benign mesothelioma, and solitary fibrous mesothelioma. Some of them are confused with sinonasal hemangiopericytoma. Sinonasal hemangiopericytoma are biologically, morphologically, and clinically very distinct from SFTs. They are thought to be intrathoracic tumors, whereas 50% to 60% of SFTs grow outside the thorax. Some of them develop in the central nervous system (CNS). Research findings suggest that solitary fibrous tumors usually affect adults (in mid-40s). They are observed equally in men and women. Some of them are observed in adolescents and children. The tumor site is broad and the tumor arises from visceral location. More than 40% of SFTs are localized in the subcutaneous tissues. Usually, dull pain and less growth are primary symptoms. These tumors can also cause hypoglycemia, as some of them exhibit production of insulin-like growth factors. About 15% to 20% of the malignant tumors may infiltrate and metastasize to a different location. Under microscope, these tumors show areas of collagen in combination with hemangiopericytoma and hypocelluarity. Typical SFTs show multinucleated giant cells with minimal cytoplasm and elongated nuclei.

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37022

The global solitary fibrous tumor (SFT) treatment market is estimated to expand rapidly in the next few years. Some of the driving factors for the market are increase in the incidence of cancers, rise in geriatric population worldwide, increase in awareness about cancer and its recurrence, technological advancements, and adoption of newly developed, minimally invasive techniques. Additionally, increase in investments by pharmaceutical and biotechnology companies to develop new molecular entities, advancements in chemotherapy, and better reimbursement policies in developed countries are a few key factors anticipated to augment the global solitary fibrous tumor (SFT) treatment market during the forecast period. However, side-effects caused by chemotherapy, increase in the cost of treatment, and lack of skilled professionals hinder the global solitary fibrous tumor (SFT) treatment market.

Based on type of treatment, the global solitary fibrous tumor (SFT) treatment market can be segmented into surgery, radiation therapy, and adjuvant chemotherapy. To date, research findings have not been able to figure out which treatment is superior. For example, if SFTs appear malignant, then adjuvant radiation therapy can be a good option. While in some of them, complete excision is generally preferred. After surgery or chemotherapy, long-term follow-up treatment is recommended by doctors, as distant or local relapse is possible, even in cases of benign tumors.

Request Report For TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=37022

Based on region, the global solitary fibrous tumor (SFT) treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to expand rapidly in the next few years, due to well-developed health care systems, proper reimbursement scenario, and adoption of new and advanced techniques in the region. North America is projected to be followed by Europe and Asia Pacific. Presence of key players, increase in investments in R&D by leading players, and alliance of key players with research institutes are some of the factors driving the global solitary fibrous tumor (SFT) treatment market.

Some of the key players operating in the global solitary fibrous tumor (SFT) treatment market are Medtronic Plc, AstraZeneca plc, Sun Pharmaceutical Industries Limited, Johnson & Johnson, Roche Ag, and Pfizer.

Enquiry for discount on this report –https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=37022

Solitary Fibrous Tumor (SFT) Treatment Market: Growth and Sales Forecast 2017 – 2025



Solitary fibrous tumor (SFT) is a rare type of tumor. It generally comprises a spectrum of benign mesenchymal tumors that have thick collagen with hemangiopericytoma. Some of them can grow as malignant tumors. SFTs were first described in 1931 and they were recognized by several different names viz. pleural fibroma, benign mesothelioma, sub-serosal fibroma, localized fibrous tumor, benign mesothelioma, and solitary fibrous mesothelioma. Some of them are confused with sinonasal hemangiopericytoma. Sinonasal hemangiopericytoma are biologically, morphologically, and clinically very distinct from SFTs. They are thought to be intrathoracic tumors, whereas 50% to 60% of SFTs grow outside the thorax. Some of them develop in the central nervous system (CNS). Research findings suggest that solitary fibrous tumors usually affect adults (in mid-40s). They are observed equally in men and women. Some of them are observed in adolescents and children. The tumor site is broad and the tumor arises from visceral location. More than 40% of SFTs are localized in the subcutaneous tissues. Usually, dull pain and less growth are primary symptoms. These tumors can also cause hypoglycemia, as some of them exhibit production of insulin-like growth factors. About 15% to 20% of the malignant tumors may infiltrate and metastasize to a different location. Under microscope, these tumors show areas of collagen in combination with hemangiopericytoma and hypocelluarity. Typical SFTs show multinucleated giant cells with minimal cytoplasm and elongated nuclei.

Get Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37022

The global solitary fibrous tumor (SFT) treatment market is estimated to expand rapidly in the next few years. Some of the driving factors for the market are increase in the incidence of cancers, rise in geriatric population worldwide, increase in awareness about cancer and its recurrence, technological advancements, and adoption of newly developed, minimally invasive techniques. Additionally, increase in investments by pharmaceutical and biotechnology companies to develop new molecular entities, advancements in chemotherapy, and better reimbursement policies in developed countries are a few key factors anticipated to augment the global solitary fibrous tumor (SFT) treatment market during the forecast period. However, side-effects caused by chemotherapy, increase in the cost of treatment, and lack of skilled professionals hinder the global solitary fibrous tumor (SFT) treatment market.

Based on type of treatment, the global solitary fibrous tumor (SFT) treatment market can be segmented into surgery, radiation therapy, and adjuvant chemotherapy. To date, research findings have not been able to figure out which treatment is superior. For example, if SFTs appear malignant, then adjuvant radiation therapy can be a good option. While in some of them, complete excision is generally preferred. After surgery or chemotherapy, long-term follow-up treatment is recommended by doctors, as distant or local relapse is possible, even in cases of benign tumors.

Request Report For TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=37022

Based on region, the global solitary fibrous tumor (SFT) treatment market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is estimated to expand rapidly in the next few years, due to well-developed health care systems, proper reimbursement scenario, and adoption of new and advanced techniques in the region. North America is projected to be followed by Europe and Asia Pacific. Presence of key players, increase in investments in R&D by leading players, and alliance of key players with research institutes are some of the factors driving the global solitary fibrous tumor (SFT) treatment market.

Some of the key players operating in the global solitary fibrous tumor (SFT) treatment market are Medtronic Plc, AstraZeneca plc, Sun Pharmaceutical Industries Limited, Johnson & Johnson, Roche Ag, and Pfizer.

Enquiry for discount on this report –https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=37022

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Solitary Fibrous Tumor (SFT) Treatment Market: Growth and Sales Forecast 2017 – 2025 here

News-ID: 959939 • Views: 161

More Releases from Transparency Market Research

Lithography Equipment Market: Study Provides In-Depth Analysis Of Automotive Flo …
TMR’s report offers a complete analysis of the global Lithography Equipment Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Lithography Equipment Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @ https://www.transparencymarketresearch.com/lithography-equipment-market.html The global Lithography Equipment Market is expected to
Automotive Lighting Market Forecast With Top Companies, Growth Factors, Classifi …
TMR’s report offers a complete analysis of the global Automotive Lighting Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Automotive Lighting Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @ https://www.transparencymarketresearch.com/automotive-lighting-market.html The global Automotive Lighting Market is expected to
Power Semiconductor Market In-Depth Analysis By Key Players, Size, Share, Trends …
TMR’s report offers a complete analysis of the global Power Semiconductor Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Power Semiconductor Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @ https://www.transparencymarketresearch.com/power-semiconductor-market.html The global Power Semiconductor Market is expected to
Photomask Market Forecast With Top Companies, Growth Factors, Classification, Re …
TMR’s report offers a complete analysis of the global Photomask Market with an in-depth analysis of facets such as notable developments, challenges, and key trends. The report also focuses on the drivers propelling the growth of the global Photomask Market. This information can help readers understand the quantitative growth prospects of the market during the forecast period. Browse Our Report @https://www.transparencymarketresearch.com/photomask-market.html The global Photomask Market is expected to show a promising CAGR

All 5 Releases


More Releases for SFT

Thermoplastic Composites Market Report: Trends, Forecast and Competitive Analysi …
According to a new market report published by Lucintel, the future of the global thermoplastic composites market looks promising with opportunities in transportation, consumer goods, industrial, and construction industries. The global thermoplastic composites market is expected to reach an estimated $16.3 billion by 2023 with a CAGR of 3.7% from 2018 to 2023. The major drivers for this market are growing demand for lightweight and environmentally sustainable materials, and the
Solitary Fibrous Tumor (SFT) Treatment Market Size, Share & Trend | Industry Ana …
Solitary fibrous tumor (SFT) is a rare type of tumor. It generally comprises a spectrum of benign mesenchymal tumors that have thick collagen with hemangiopericytoma. Some of them can grow as malignant tumors. SFTs were first described in 1931 and they were recognized by several different names viz. pleural fibroma, benign mesothelioma, sub-serosal fibroma, localized fibrous tumor, benign mesothelioma, and solitary fibrous mesothelioma. Some of them are confused with sinonasal
Explored in latest research Solitary Fibrous Tumor (SFT) Treatment Market Size & …
The report analyzes and presents an overview of "Explored in latest research Solitary Fibrous Tumor (SFT) Treatment Market Size & Share, Growth, Trends and Forecast 2017 - 2025" worldwide. The main objective of this report is to define, describe, and forecast the global “Solitary Fibrous Tumor (SFT) Treatment” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of
Lucintel identifies and prioritizes opportunities for growth in the global short …
According to a new market report published by Lucintel, the future of the short fiber thermoplastic (SFT) composites market looks attractive with opportunities in the transportation, consumer goods, and electrical/electronics industries. The global short fiber thermoplastics market is forecast to grow at a CAGR of 4.5% from 2016 to 2021. The major drivers for the growth of this market are recyclability, ease of processing, and better capability of making parts
Lucintel identifies and prioritizes opportunities for growth in the global short …
According to a new market report published by Lucintel, the future of the short fiber thermoplastic (SFT) composites market looks attractive with opportunities in the transportation, consumer goods, and electrical/electronics industries. The global short fiber thermoplastics market is forecast to grow at a CAGR of 4.5% from 2016 to 2021. The major drivers for the growth of this market are recyclability, ease of processing, and better capability of making parts
i-sft offers individual flat displays without non-recurring engineering costs
At i-sft.com, customers can specify individual electronic display units Gundersheim, 5 August 2013. German-based company i-sft GmbH has just announced that it will offer various designs for individual electronic display units without any non-recurring costs for development. On the new website www.i-sft.com, the specifications of many available technology platforms can now be downloaded as PDF files. Potential buyers can request their own modifications, or they can cover a very wide range